4. Medical marijuana could curb opioid abuse Legalization has helped curb prescription drug, or opioid, overdose deaths, according to a study conducted by Dr. Colleen Barry, a research professor at Johns Hopkins Bloomberg School of Public Health. Barry’s study was published last year by The Journal of the American Medical Association. Even though there could be multiple reasons for fewer prescription drug overdose deaths, it is a strong possibility that the availability of medical marijuana has changed the behavior of people who are addicted to and abuse opioids, Barry testified. 5. Tracking with data and technology If legalized, medical marijuana distribution in Pennsylvania would be regulated by a Medical Cannabis Licensing Board.
For the original version including any supplementary images or video, visit http://www.eveningsun.com/local/ci_27593480/hearings-medical-cannabis-act-begin-today-harrisburg?source=rss
Becker, Jamie. The State of Marijuana in the U.S. in 2015; Lifelines; February 2015. lhsfna.org/index.cfm/lifelines/february-2015/the-state-of-marijuana-in-the-u-s-in-2015/ 3. Macdonald, Scott; Wayne Hall; et al. Testing for Cannabis in the Work-Place: A Review of the Evidence; Addiction; March 2010. onlinelibrary.wiley.com/doi/10.1111/j.1360-0443.2009.02808.x/abstract 4. Zwerling, Craig; James Ryan; and Endel John Orav.
For the original version including any supplementary images or video, visit http://www.prweb.com/releases/2015/02/prweb12530889.htm
In January of 2015, prices had spiked to $2185 increased for medicinal marijuana In California, which was the estimate used to derive sales numbers. Using adjusted conservative numbers of only 1 pound per plant as a yield and $1350 which was the lowest price sold for in 2014 after upgrades to property, Medicated Markets would yield $13.5 million for 2015 or $3.37 million quarterly. If a conservative SG&A of 30% were used, it would result in a profit of $2.359 Million of which Easton would be allocated 40% ownership or $943,000 per quarter. This is nearly a 100% Return on equity paid for in restricted shares in 1 year of operation. Medicated Markets were provided an initial upfront cash payment and issued “rule 144 restricted shares” (which are in escrow till maturity) and not free trading shares. These shares were valued at .02 giving the transaction a value of $4,000,000. Many have noted negative trading activity in Easton pharmaceutical stock in the month of February.
For the original version including any supplementary images or video, visit http://finance.yahoo.com/news/easton-pharmaceuticals-discloses-existing-medicated-140000087.html
While he could not specify the bill’s language, state Rep. Jim Cox, R-Berks County, said his goal is to help as many people as possible in as many ways as possible with the drug and its delivery methods. State Sen. Mike Folmer, R-Lebanon County, presented the Medical Cannabis Act, or Senate Bill 3, last month. That bill would legalize medical marijuana for a list of 10 conditions with a state Board of Medical Cannabis Licensing. As it stands, smoking marijuana is not an allowable use for treatment in S.B. 3.
For the original version including any supplementary images or video, visit http://www.ydr.com/politics/ci_27565946/rep-jim-coxs-medical-marijuana-bill-pa-house?source=rss
Mike Folmer’s office. Slated to testify at the Feb. 25 hearing held by the Senate State Government Committee are Drs. Steven Shapiro and Bruce MacLeod from the Pennsylvania Medical Society, which has been reluctant to legalize medical marijuana without more research. Dr. Jeffrey Raber and Paul Taylor will speak about delivery of medical marijuana while Drs. Jack D’Angelo, Colleen Barry and Thomas Trite will speak about medical cannabis research, according to the release from Folmer’s office. Folmer, who introduced the Medical Cannabis Act last month , chairs the Senate State Government Committee. The hearing’s purpose is to discuss possible amendments to the bill, which is similar to the medical marijuana bill that cleared the Senate last year. Legislators have expressed an interest in allowing doctors to determine what conditions can be treated with medical cannabis rather than lawmakers. The bill contains a list of 10 ailments that could be treated with medical cannabis including cancer, epilepsy, Parkinson’s disease, post-traumatic stress disorder and multiple sclerosis.
For the original version including any supplementary images or video, visit http://www.ydr.com/politics/ci_27550701/nine-testify-state-senate-about-medical-marijuana?source=rss
Within the cannabis industry, Nemus Bioscience’s team is unparalleled for a company of its size, putting it alongside larger competitors like GW Pharmaceuticals plc (NASDAQ:GWPH) in terms of talent. CEO John Hollister, MBA, leads the team at Nemus Bioscience with over 25 years of leadership experience in the pharmaceutical industry, from start-ups to blue chips. As a strategic consultant, he has worked with a variety of early stage companies to refine their plans, while he was involved in hands-on work with companies like GlaxoSmithKline plc (NYSE:GSK) and Amgen Inc. (NASDAQ:AMGN) bringing products through clinical trials. CMO Brian Murphy, MD, MPH, MBA, contributes more than 15 years of experience in drug development and evaluation to the team from both small and large companies. With a background in business, academia, and medicine, Dr. Murphy has diverse talents and a unique perspective on the market from all angles. CFO Elizabeth Berecz, MA, CPA, rounds out the team with over 20 years of experience holding senior level positions in both private and public companies. With significant experience in strategic planning, financial reporting, and global systems integrations for companies of various sizes, she brings an air of financial credibility to the micro-cap company, which further differentiates itself in a space that remains somewhat foreign to investors. Looking Ahead to the Future Nemus Bioscience’s exclusive university partnership has provided it with a proprietary delivery mechanism for cannabinoids and a pro-drug platform that could allow the therapy to evade first-pass metabolism by the liver thereby optimizing delivery in a more predictable and reliable way.
For the original version including any supplementary images or video, visit http://finance.yahoo.com/news/nemus-unlocks-cannabinoid-potential-unique-142000586.html
“The purpose of presenting this extension of the moratorium is really to give the legislature an opportunity to address the medical marijuana issue in the legislature, which they have said they are going to do,” said city manager Joseph Gavinski. Lawmakers are expected to discuss certain amendments to Initiative-502, which will modify existing laws in relation to medical marijuana gardens. I-502 was passed by Washington voters in the 2012 November general election and legalized the production, possession, delivery, distribution and sale of marijuana for persons age 21 and older. The council concluded it was of “public interest” to extend the moratorium because the city has no way of determining what will be decided at the session. “They (Legislature) came close last year, I think they feel a little bit more pressure to get this done, understanding that it needs to be done,” Gavinski said. “There has to be some reconciliation in a lot of people’s minds between the recreational marijuana and the medical marijuana. And that’s really what we need in order to give some clarity here to the city council, the citizens of this community.” According to the Revised Code of Washington (RCW), qualifying medical marijuana patients are allowed to create and participate in collective gardens for the purpose of producing, processing, transporting and delivering marijuana for medical use. The RCW does have some restrictions however, as no more than 10 patients are allowed to participate in a single collective garden at a time, the collective garden can contain no more than 15 plants per patient and up to 45 plants total, and the garden cannot contain more than 24 ounces of usable marijuana per patient and up to 72 ounces total. In addition, usable marijuana from the garden can only be delivered to qualifying patients, according to the RCW.
For the original version including any supplementary images or video, visit http://www.columbiabasinherald.com/politics/moses-lake-extends-halt-on-medical-marijuana-gardens/article_d41f2502-b30f-11e4-a6a8-0bf6f390bd5e.html
Similar apps have popped up in other cities such as Los Angeles, and in some cases theyve been driven out of town. Almost 100 orders have been processed since the app launched just two weeks ago, but according to the city, delivering pot to your door is not allowed. Sacramento State graduate Stephen Found developed the Sacramento-based medical-marijuana delivery service app called Clevertree. It provides the technology, while local dispensaries provide the product and drivers. Theres all kinds of startups doing this kind of work in all kinds of industries so its really changing the way we are living our lives, he said. The city says a dispensary could lose its license if it is caught, but it also says the ordinance isnt enforced unless someone complains. So far, it hasnt received any complaints. Canna Care dispensary owner Lanette Davies has patients who are too sick to come in, or others who want to avoid being seen at the dispensary, but shes not ready to send any of her employees to someones home. We have to keep the public safe, keep the employees safe and we have to know where our product is at all times, she said. However, Foung says apps like his, no matter what industry they cater to, are the new way to do business. Technology changes our world so fast that some laws, even 5, 10 years ago, are pretty much outdated now, he said.
For the original version including any supplementary images or video, visit http://sacramento.cbslocal.com/2015/02/09/sacramento-medical-marijuana-delivery-app-may-conflict-with-city-law/
People still think you have to medicate with a joint or bong, its not that way anymore.” Users create an account, supply their address and Meadow dispatches a doctor to their door. Appointments are same day and each examination takes between 15 and 45 minutes. If the doctor decides a recommendation for marijuana is appropriate, patients pay a flat fee of $100. Those who don’t get a recommendation are not charged. CannabisMD also offers renewals medical marijuana patients typically need to get their recommendations renewed each year which can be done over Skype for a $50 fee. The company says it personally vets each physician it works with to ensure they have a deep understanding of how cannabis is used to treat various conditions, down to which strains and applications are most appropriate for specific ailments. Meadow will also continue to offer its delivery service, which allows people to place online orders from local dispensaries for same day delivery, though Hua notes the delivery service and CannabisMD are separate and doctors are instructed not to recommend specific dispensaries, only forms of treatment. A screenshot of Meadow’s delivery service where people can shop online from local dispensaries. Image: Meadow The company, one of a handful of marijuana delivery services that have cropped up recently, launched an app last October but removed it from the App Store and Google Play after the stores restricted Meadow’s ability to charge users, due to their policies around drug content in apps.
For the original version including any supplementary images or video, visit http://mashable.com/2015/02/04/meadow-cannabis-md/?utm_campaign=Mash-Prod-RSS-Feedburner-All-Partial&utm_cid=Mash-Prod-RSS-Feedburner-All-Partial&utm_medium=feed&utm_source=rss
Both measures passed but the citys initiative received more votes, 65.9 percent. Under the citys measure, medical marijuana dispensaries can only operate in two industrial parts of the city. They cannot be clustered or within 1,000 feet of any park, school or residential area. No cultivation is allowed. Tinajero said Santa Ana is now prepared for 2016, when marijuana advocates are expected to try to get a statewide measure passed to legalize recreational marijuana use. By having something in place, weve already set the standard of where we would allow any type of cannabis sales in the city to occur, he said. The city of Costa Mesa is in the middle of creating an ordinance to regulate medical marijuana dispensaries there. It, too, was forced into regulation by a coalition of marijuana advocates. Randall Longwith, an attorney who represents dispensary owners, led a petition effort to place marijuana regulations on the Costa Mesa ballot in March. Thats been delayed and advocates are threatening legal action. Longwith is using the voter referendum as a tool to pressure other cities too–Westminster is next–into legalizing the dispensaries.
For the original version including any supplementary images or video, visit http://www.scpr.org/news/2015/02/04/49667/medical-marijuana-shops-will-legally-operate-in-sa/